Biosimilars: A Global Perspective of a New Market - Opportunities, Threats and Critical Strategies 2014: Enterprise

 Preview

Report / Survey by Thomson Reuters BioWorld , 09/30/2014

Mari Serebrov

Interactive PDF of data, projections, and analysis
>100 deals involving follow-on biologics (FOBs) identified
700 biosimilars and 245 companies profiled
Updates on approvals and pipeline developments
Analysis of competitive landscape, defensive strategies, and market share
Market/regulatory analysis of 25 countries in Europe, Asia/Pacific, Latin America, Middle East, Africa, and North America
Core drivers and IP issues impacting biosimilar growth
and much more

Single-user version also available. See more

Delivery Options

Self Extracting File Format

Language

Users

Price: $7,995.00

Available for Immediate Download

09/30/2014

268

1 file

Device/OS:	Unknown
Browser:	Unknown Browser 0.0
User Agent:	Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)
Store Name:	css
Page:	/standards/biosimilars-a-global-perspective-of-a-new-market-opportunities-threats-and-critical-strategies-2014-enterprise?product_id=1888248
Referrer:	Direct Navigation
IP:	216.73.216.32
Language:	en
Customer #:	Not Logged In
Member?:	NO
Cart #:	1463761697
Order #:	None
Cookies:	NO

What is a Secured PDF?